1. Home
  2. RVLV vs CRNX Comparison

RVLV vs CRNX Comparison

Compare RVLV & CRNX Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

  • Machine Learning Prediction
  • ML Decision
  • RVLV
  • CRNX
  • Stock Information
  • Founded
  • RVLV 2003
  • CRNX 2008
  • Country
  • RVLV United States
  • CRNX United States
  • Employees
  • RVLV N/A
  • CRNX N/A
  • Industry
  • RVLV Catalog/Specialty Distribution
  • CRNX Biotechnology: Pharmaceutical Preparations
  • Sector
  • RVLV Consumer Discretionary
  • CRNX Health Care
  • Exchange
  • RVLV Nasdaq
  • CRNX Nasdaq
  • Market Cap
  • RVLV N/A
  • CRNX 2.8B
  • IPO Year
  • RVLV 2019
  • CRNX 2018
  • Fundamental
  • Price
  • RVLV $21.37
  • CRNX $30.00
  • Analyst Decision
  • RVLV Buy
  • CRNX Strong Buy
  • Analyst Count
  • RVLV 15
  • CRNX 10
  • Target Price
  • RVLV $26.20
  • CRNX $75.00
  • AVG Volume (30 Days)
  • RVLV 1.2M
  • CRNX 646.9K
  • Earning Date
  • RVLV 08-05-2025
  • CRNX 08-07-2025
  • Dividend Yield
  • RVLV N/A
  • CRNX N/A
  • EPS Growth
  • RVLV 106.68
  • CRNX N/A
  • EPS
  • RVLV 0.71
  • CRNX N/A
  • Revenue
  • RVLV $1,156,039,000.00
  • CRNX $760,000.00
  • Revenue This Year
  • RVLV $7.71
  • CRNX $402.12
  • Revenue Next Year
  • RVLV $7.64
  • CRNX $770.88
  • P/E Ratio
  • RVLV $30.15
  • CRNX N/A
  • Revenue Growth
  • RVLV 9.09
  • CRNX N/A
  • 52 Week Low
  • RVLV $14.88
  • CRNX $24.10
  • 52 Week High
  • RVLV $39.58
  • CRNX $62.53
  • Technical
  • Relative Strength Index (RSI)
  • RVLV 54.29
  • CRNX 44.17
  • Support Level
  • RVLV $19.93
  • CRNX $28.34
  • Resistance Level
  • RVLV $21.93
  • CRNX $30.01
  • Average True Range (ATR)
  • RVLV 0.86
  • CRNX 1.07
  • MACD
  • RVLV 0.05
  • CRNX -0.17
  • Stochastic Oscillator
  • RVLV 71.67
  • CRNX 36.41

About CRNX Crinetics Pharmaceuticals Inc.

Crinetics Pharmaceuticals Inc is a clinical-stage pharmaceutical company focused on the discovery, development, and commercialization of novel therapeutics for rare endocrine diseases and endocrine-related tumors. Its products include Paltusotine and Atumelnant.

Share on Social Networks: